Don Dizon, MD, Oncology, Providence, RI, Rhode Island Hospital

DonSDizonMDFACP

OncologyProvidence, RI

Breast Cancer, Gynecologic Cancer, Hematologic Oncology, Complementary and Integrative

Professor of Medicine, Brown University

Dr. Dizon is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Dizon's full profile

Already have an account?

Summary

  • I am an academic medical gynecologic oncologist with a special interest in cancer survivorship, particularly as it relates to sexual health. I have published extensively in the area of cancer survivorship in women with a gynecologic or breast cancer and speak nationally and internationally on topics related to these issues. I have held leadership positions in academic oncology in multiple institutions and have also served in leadership positions within the American Society of Clinical Oncology, NRG Oncology (formerly Gynecologic Oncology Group), and the NIH, where I am currently co-chair the Cervix Cancer Task Force for the Gynecologic Cancer Steering Committee. I have published extensively in my areas of interest and within the area of cancer survivorship.
  • I Live to Conquer Cancer - ASCO Campaign

    Don S. Dizon, MD, FACP, FASCO, an oncologist at the Lifespan Cancer Institute at Rhode Island Hospital, shares his passion for treating each person with cancer

    Meet Dr. Don Dizon

    Don S. Dizon, MD, is an oncologist who specializes in women's cancers. He is the director of women's cancers at Lifespan Cancer Institute and is director of med

Education & Training

  • Memorial Sloan-Kettering Cancer Center
    Memorial Sloan-Kettering Cancer CenterFellowship
  • Yale-New Haven Hospital
    Yale-New Haven HospitalResidency
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryMedicalSchool
  • University of Rochester
    University of RochesterOtherTraining

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2004 - 2019
  • RI State Medical License
    RI State Medical License 2003 - 2020
  • CT State Medical License
    CT State Medical License 1998 - 2012
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors for Cancer Castle Connolly, 2011-2013, 2015
  • America's Top Doctors Castle Connolly, 2012-2014
  • Dean’s Teaching Warren Alpert Medical School of Brown University, 2008, 2010, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Personalizing chemotherapy through genetic profiling: will pharmacogenomics help improve and extend life for cancer patients?  
    K Hachey and DS Dizon, Personalized Medicine, 2009; 6:481-4
  • Dyspareunia and vaginal dryness after breast cancer treatment.  
    DL Wiggins and DS Dizon, Sexuality, Reproduction, and Menopause, 2008: 18-22
  • HER dimerization inhibitors: Developing pertuzumab as an anti-cancer agent in women’s oncology.  
    DS Dizon and S Makhija, Expert Opinion in Drug Discovery, 2008; 11:1363-69
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • A subset of genes is upregulated in the SKOV-3 cell line following treatment with cisplatin, following development of platinum-resistance, and after transfection of an...
    DS Dizon, XJ Yan, N Rosales, CA Aghajanian, DR Spriggs, National Cancer Institute/European Organization for Research and Treatment of Cancer, American Association for Cancer Research (NCI/EORTC/AACR) Oncogenomics Conference 2002. Dublin, Irel
  • Early Finding in a Phase I study of the novel high affinity VEGF binder VEGF Trap in patients with refractory solid tumors and lymphoma.
    J Dupont, C Aghajanian, P Chapman, D Dizon, J Koutcher, L Krug, R Motzer, P Sabbatini, L Schwartz, S Sharma, D Camastra, S Pezzulli, V Ty, M Gordon, J Murren, A Lucare..., National Cancer Institute/European Organization for Research and Treatment of Cancer, American Association for Cancer Research (NCI/EORTC/AACR) International Conference
  • Phase I/II Dose-Escalation Trial of Patupilone Every 3 Weeks in Patients with Platinum-Resistant/Refractory Ovarian Cancer.
    WW ten Bokkel Huinik, WM Smit, J Sufliarsky, DS Dizon, AM Oza, J-M Culillerot, KJ Williams, A Johri, International Gynecologic Cancer Society Annual Meeting, Santa Monica, CA
  • Join now to see all

Lectures

  • New Approaches for Less Studied Tumors 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
  • New Strategies in the clinical treatment of endometrial cancer. 
    The Chemotherapy Foundation Symposium XXVII, New York City
  • Screening Mammography in Women Aged 40-49. 
    National Consortium of Breast Centers Annual Meeting, Las Vegas
  • Join now to see all

Other

  • Quality of life after breast cancer: survivorship and sexuality. 
    DS Dizon, The Breast Journal. 2009; 15:500-4
  • Treatment options for advanced endometrial cancer. 
    DS Dizon, Gynecologic Oncology 2010; 117:373-81
  • Where do anti-angiogenic agents belong in the treatment algorithm for ovarian cancer? 
    DS Dizon, American J Clin Oncol, 2011
  • Join now to see all

Authored Content

  • As an Oncologist, This Is the Hardest Role I PlayJuly 2020

Press Mentions

  • His COVID-19 Status, Deformed Tumor BoardsApril 28, 2020
  • Vaccine Combo 'Provocative' as Cervical Cancer TreatmentMarch 27, 2020
  • The Extrovert's Guide to Social DistancingMarch 23, 2020
  • Join now to see all

Professional Memberships

Hospital Affiliations